AAX Biotech AB – Trademark Portfolio

Entity Type: 98

AAX Biotech AB holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include SEQITOPE.

Nanna Svartz Väg 4

SE-171 65 Solna

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AAX Biotech AB's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does AAX Biotech AB have?

AAX Biotech AB has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does AAX Biotech AB file in?

AAX Biotech AB files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are AAX Biotech AB's most well-known trademarks?

AAX Biotech AB's registered trademark portfolio includes well-known marks such as SEQITOPE. These are among 1 currently registered trademark in the portfolio.

What is AAX Biotech AB's trademark registration success rate?

AAX Biotech AB has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.